Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule

European Journal of Health Economics

Volumn 6, Issue 3, 2005, Pages 203-214

  Lejeune, Catherine ^a,f   Al Zahouri, Kazem ^b   Woronoff Lemsi, Marie Christine ^c   Arveux, Patrick ^a,d   Bernard, Alain ^e   Binquet, Christine ^a,e   Guillemin, Francis ^b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Hopital Marin   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d CENTRE GEORGES FRANÇOIS LECLERC   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

Author keywords

Cost effectiveness; Decision modeling; Positron emission tomography; Program evaluation; Solitary pulmonary nodule

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA BASE; DECISION MAKING; EVALUATION; HEALTH ECONOMICS; HUMAN; LUNG NODULE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT;

AGED; COIN LESION, PULMONARY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FLUORODEOXYGLUCOSE F18; FRANCE; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; LUNG NEOPLASMS; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 27844546585     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-005-0279-0     Document Type: Article

References (56)

1. Berrino F, Copocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A (1999) Survival of cancer patients in Europe: the EUROCARE-2 study. IARC: Lyon
2. Hanley KS, Rubins JB (2003) Classifying solitary pulmonary nodules. New imaging methods to distinguish malignant, benign lesions. Postgrad Med 114:29-35
3. Bernard A, Binquet C, Lejeune C, Hagry C, Quantin C, Faivre J, Favre JP (2002) A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter. Rev Mal Respir 19:569-576
4. Kunstaetter R, Wolkove N, Kreisman H, Cohen C, Frank H (1985) The solitary pulmonary nodule. Decision analysis. Med Decis Making 5:61-75
5. Gupta NC, Maloof J, Gunel E (1996) Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 37:943-948
6. Bury T, Dowlati A, Paulus P, Corhay JL, Benoit T, Kayembe JM, Limet R, Rigo P, Radermecker M (1996) Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 9:410-414
7. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG (1995) Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 110:130-140
8. Hung GU, Shiau YC, Tsai SC, Ho YJ, Kao CH, Yen RF (2001) Differentiation of radiographically indeterminate solitary pulmonary nodules with [18F]fluoro-2-deoxyglucose positron emission tomography. Jpn J Clin Oncol 31:51-54
9. Halter G, Storck M, Guhlmann A, Frank J, Grosse S, Liewald F (2000) FDG positron emission tomography in the diagnosis of peripheral pulmonary focal lesions. Thorac Cardiovasc Surg 48:97-101
10. Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H (2000) Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med 27:1441-1456
11. Gambhir SS, Shepherd JE, Shah BD (1998) Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 16:2113-2125
12. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914-924
13. Santambrogio L, Nosotti M, Bellaviti N, Pavoni G, Radice F, Caputo V (1997) CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation. Chest 112:423-425
14. Wicky S, Mayor B, Cuttat JF, Schnyder P (1994) CT-guided localizations of pulmonary nodules with methylene blue injections for thoracoscopic resections. Chest 106:1326-1328
15. Siegelman SS, Khouri NF, Leo FP, Fishman EK, Braverman RM, Zerhouni EA (1986) Solitary pulmonary nodules: CT assessment. Radiology 160:307-312
16. Bourguet P (2003) Standards, options and recommendations for the use of PET-FDG in cancerology. Bull Cancer 90:34-39
17. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99-105
18. Steele JD, Buell P (1973) Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate. J Thorac Cardiovasc Surg 65:140-151
19. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI (2000) Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 217:251-256
20. Midthun DE, Swensen SJ, Jett JR (1992) Clinical strategies for solitary pulmonary nodule. Annu Rev Med 43:195-208
21. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13:322-338
22. Mack MJ, Hazelrigg SR, Landreneau RJ, Acuff TE (1993) Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg 56:825-830
23. Bernard A (1996) Resection of pulmonary nodules using video-assisted thoracic surgery. The Thorax Group. Ann Thorac Surg 61:202-204
24. Greene R, Szyfelbein WM, Isler RJ, Stark P, Janstsch H (1985) Supplementary tissue-core histology from fine-needle transthoracic aspiration biopsy. AJR Am J Roentgenol 144:787-792
25. Charig MJ, Phillips AJ (2000) CT-guided cutting needle biopsy of lung lesions-safety and efficacy of an out-patient service. Clin Radiol 55:964-969
26. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ (1995) PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest 108:441-446
27. Charig MJ, Stutley JE, Padley SP, Hansell DM (1991) The value of negative needle biopsy in suspected operable lung cancer. Clin Radiol 44:147-149
28. Al-Damegh S (2001) Fine needle aspiration of solitary pulmonary lesions. Eur J Radiol 37:200-203
29. Dennie CJ, Matzinger FR, Marriner JR, Maziak DE (2001) Transthoracic needle biopsy of the lung: results of early discharge in 506 outpatients. Radiology 219:247-251
30. Richardson CM, Pointon KS, Manhire AR, Macfarlane JT (2002) Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies. Br J Radiol 75:731-735
31. Duque JL, Ramos G, Castrodeza J, Cerezal J, Castanedo M, Yuste MG, Heras F (1997) Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica. Ann Thorac Surg 63:944-950
32. Zwirewich CV, Vedal S, Miller RR, Muller NL (1991) Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 179:469-476
33. Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthun DE (1996) Lung nodule enhancement at CT: prospective findings. Radiology 201:447-455
34. Prauer HW, Weber WA, Romer W, Treumann T, Ziegler SI, Schwaiger M (1998) Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg 85:1506-1511
35. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T (1990) Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31:1927-1932
36. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE (1998) Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16:1075-1084
37. Detsky AS, Naglie G, Krahn MD, Redelmeier DA, Naimark D (1997) Primer on medical decision analysis. II. Building a tree. Med Decis Making 17:126-135
38. Cummings SR, Lillington GA, Richard RJ (1986) Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. Am Rev Respir Dis 134:449-452
39. Beck JR, Kassirer JP, Pauker SG (1982) A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med 73:883-888
40. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP (1982) A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med 73:889-897
41. Beck JR, Pauker SG (1999) Does DEALE-ing stack the deck? Med Decis Making 19:503-504
42. Beaumel C, Doisneau L, Vatan M (2002) Life tables 1997-1999. In: Demographic situation in 1999, vol 3, p 202. INSEE: Paris
43. Lopez-Encuentra A, Bulzebruck H, Feinstein AR, Motta G, Mountain CF, Naruke T, Sanchez JM, Tsuchiya R, Wittekind C (2000) Tumor staging and classification in lung cancer. Summary of the international symposium. Madrid, Spain, 3-4 December 1999. Lung Cancer 29:79-83
44. Gail MH, Eagan RT, Feld R, Ginsberg R, Goodell B, Hill L, Holmes EC, Lukeman JM, Mountain CF, Oldham RK et al. (1984) Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 54:1802-1813
45. Black WC, Armstrong P, Daniel TM (1988) Cost effectiveness of chest CT in T1N0M0 lung cancer. Radiology 167:373-378
46. Jackman RJ, Good CA, Clagett OT, Woolner LB (1969) Survival rates in peripheral bronchogenic carcinomas up to four centimeters in diameter presenting as solitary pulmonary nodules. J Thorac Cardiovasc Surg 57:1-8
47. Santambrogio L, Nosotti M, Bellaviti N, Mezzetti M (1995) Videothoracoscopy versus thoracotomy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg 59:868-870
48. Bergeal E (2000) Economic evaluation of positron emission tomography: the Champardennais project. Thesis, Reims University
49. Fauchet M, Vernon JD (1998) Positron emission tomography in clinical routine: financial and industrial perspectives. RBM 20:180-182
50. Drummond MF, Jefferson TO (1996) Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 313:275-283
51. Elixhauser A, Halpern M, Schmier J, Luce BR (1998) Health care CBA and CEA from 1991 to 1996: an up-dated bibliography. Med Care 36: MS18-147
52. Laupacis A, Feeny D, Detsky AS, Tugwell PX (1992) How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 146:473-481
53. Raftery J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 323:1300-1303
54. Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK (2003) Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 138:724-735
55. Barton P, Bryan S, Robinson S (2004) Modelling in the economic evaluation of health care: selecting the appriopriate approach. J Health Serv Res Policy 9:110-118
56. Karnon J (2003) Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation. Health Econ 12:837-848